Neuroendocrine neoplasms (NENs) can be difficult to detect, and many patients face long delays before receiving an accurate diagnosis. In many cases, NENs are not
By Carrie Camino, Member, NETRF Board of Directors Last month I had the extraordinary opportunity to attend the American Association of Cancer Research (AACR) as
By Anna C. Greene, PhD, NETRF Chief Scientific Officer The American Association for Cancer Research Annual Meeting, known as AACR, is one of the largest
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Two recent NETRF-funded studies are offering new insight into how neuroendocrine tumors grow, spread, and respond
At the Neuroendocrine Tumor Research Foundation (NETRF), we support research that can move the field forward, not only by advancing new treatments, but also by
By Anna C. Greene, PhD, NETRF Chief Scientific Officer A new multi-institutional study provides one of the most comprehensive pictures to date of what life
Tijana Jovanovic-Talisman, PhD, is an Associate Professor at Beckman Research Institute at City of Hope and a 2025 NETRF Pilot Award grantee for her research
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Scientists are discovering that where a tumor grows in the body may influence how it behaves.
For many families affected by neuroendocrine cancer, supporting research becomes a deeply personal mission. For Wayne Firsty and his children, Shay and Alana, that commitment
Clinical Trials Highlight Advances in Neuroendocrine Tumor Research Research into neuroendocrine tumors (NETs) continues to progress, with clinical trials exploring both new treatment approaches and